课题基金 / 基金详情

Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress

Modulation of Nociceptin/Orphanin FQ on Hypocretin Neurons in Pain and Stress
痛敏肽/孤啡肽 FQ 对疼痛和压力下下丘脑分泌素神经元的调节
批准号:
8117803
负责人:
Xinmin Simon Xie
金额:
$32.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-18 至 2013-03-30

项目摘要

项目成果

Xinmin Simon Xie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nociceptin/orphanin FQ (N/OFQ), via its receptor NOP, modulates nociception, stress, and anxiety. N/OFQ is regarded as an anti-opiate peptide because central N/OFQ causes pronociception and reversal of stress- induced analgesia (SIA). However, N/OFQ can affect nonopioid-mediated analgesia, and its anxiolytic effect is unlikely to be mediated through interaction with the opiate system. Both N/OFQ and NOP are abundant in the hypothalamus, where hypocretins/orexins (Hcrts) are selectively synthesized. The Hcrts regulate wakefulness and alertness, modulate nociceptive processing, and contribute to SIA. Because N/OFQ and Hcrts produce opposite modulations for most behaviors and cellular actions assessed, we hypothesize that N/OFQ exerts its effects on neurobehavior, primarily SIA and fear or stress-induced anxiety-like behavior, through direct modulation of Hcrt neuronal activity in the lateral hypothalamus (LH) and/or interaction at the projected sites that receive both N/OFQ and Hcrt inputs and co-express their cognate receptors. Our preliminary studies show that N/OFQ-containing fibers contact Hcrt neurons and that N/OFQ inhibits Hcrt neuronal activity via both pre- and postsynaptic mechanisms. N/OFQ also depresses cytoplasmic Ca2+ in a majority of the Hcrt neurons in orexin/cameleon 2.1 mouse hypothalamic slices. We found that orexin/ataxin-3 neurodegenerative (orexin/ataxin-3) mice exhibit no SIA in the restraint model. Conversely, intracerebroventricular (icv) administration of Hcrt mimicked SIA in orexin/ataxin-3 mice animals but prevented SIA in wildtype (WT) mice. Furthermore, exogenous Hcrt restored SIA in animals treated with centrally administered N/OFQ. These preliminary results support our hypothesis and lead us to propose the following Specific Aims: 1. Test the hypothesis that N/OFQ-containing fibers contact Hcrt neurons and determine the anatomical source(s) of N/OFQ innervation by using standard anatomical techniques (e.g., immunohistochemistry, in situ hybridization, and retrograde tracing). We will use using multiple labeling quantitative electron microscopical (EM) techniques to further determine whether N/OFQ-containing fibers synaptically contact Hcrt neurons. 2. Characterize the cellular physiological modulation of N/OFQ on Hcrt neurons by using patch clamp recordings of Hcrt neurons from orexin/EGFP mice and by Ca2+ imaging using orexin/cameleon 2.1 mice. 3. Test the hypothesis that N/OFQ blocks SIA partly through the modulation of the Hcrt system by investigating N/OFQ effects on nociceptive processing in WT and orexin/ataxin-3 mice. 4. Test the hypothesis that N/OFQ exerts anxiolytic-like effects partly via inhibition of the Hcrt-mediated stress and anxiety responses in mice using both conditioned and unconditioned fear paradigms. The proposed research will reveal whether there is an integrated neuronal circuit linking the N/OFQ and Hcrt systems that provides a dual-modulation to balance stress responses particularly related to nociceptive processing and stress adaptation.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acsnano.6b06104
发表时间: 2017-01-24
期刊: ACS nano
影响因子: 17.1
作者: [Xie X, Pascual C, Lieu C, Oh S, Wang J, Zou B, Xie J, Li Z, Xie J, Yeomans DC, Wu MX, Xie XS]
通讯作者: Xie XS
Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity.
N/OFQ 反渗析到伏隔核壳中可阻断可卡因诱导的细胞外多巴胺和运动活性的增加。
DOI: 10.1016/j.ejphar.2012.11.050
发表时间: 2013
期刊: European journal of pharmacology
影响因子: 5
作者: [Vazquez-DeRose,Jacqueline, Stauber,Gregory, Khroyan,TalineV, Xie,XinminSimon, Zaveri,NurulainT, Toll,Lawrence]
通讯作者: Toll,Lawrence
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
  • 批准号:
    10760089
  • 项目类别:
  • 资助金额:
    $149.99万
  • 财政年份:
    2023
  • 负责人:
    Xinmin Simon Xie
  • 依托单位:
Developing a novel treatment of cocaine use disorder using an IND dual inhibitor of Cav3 channel and soluble epoxide hydrolase
  • 批准号:
    10786151
  • 项目类别:
  • 资助金额:
    $31.95万
  • 财政年份:
    2023
  • 负责人:
    Xinmin Simon Xie
  • 依托单位:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
  • 批准号:
    10815882
  • 项目类别:
  • 资助金额:
    $48.39万
  • 财政年份:
    2023
  • 负责人:
    Xinmin Simon Xie
  • 依托单位:
Development of selective Cav3 channel blockers for treatment of neuropathic pain
  • 批准号:
    8779431
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2014
  • 负责人:
    Xinmin Simon Xie
  • 依托单位:
海外基金